Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1β production in human macrophages

Journal of Immunology

Volumn 187, Issue 5, 2011, Pages 2540-2547

  Novikov, Aleksey ^a,b,c   Cardone, Marco ^d   Thompson, Robert ^a   Shenderov, Kevin ^a   Kirschman, Kevin D ^e   Mayer Barber, Katrin D ^a   Myers, Timothy G ^a   Rabin, Ronald L ^e   Trinchieri, Giorgio ^a,d   Sher, Alan ^a   Feng, Carl G ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c BROWN UNIVERSITY   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; INTERLEUKIN 1BETA; MESSENGER RNA;

ARTICLE; BACTERIAL VIRULENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNITY; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE I; INTERLEUKIN-1BETA; MACROPHAGES; MYCOBACTERIUM TUBERCULOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 80052669048     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100926     Document Type: Article

References (49)

1. Cosma, C. L., D. R. Sherman, and L. Ramakrishnan. 2003. The secret lives of the pathogenic mycobacteria. Annu. Rev. Microbiol. 57: 641-676. (Pubitemid 37392957)
2. Monack, D. M., A. Mueller, and S. Falkow. 2004. Persistent bacterial infections: the interface of the pathogen and the host immune system. Nat. Rev. Microbiol. 2: 747-765. (Pubitemid 39200066)
3. Shi, S., A. Blumenthal, C. M. Hickey, S. Gandotra, D. Levy, and S. Ehrt. 2005. Expression of many immunologically important genes in Mycobacterium tuberculosis-infected macrophages is independent of both TLR2 and TLR4 but dependent on IFN-αβ receptor and STAT1. J. Immunol. 175: 3318-3328. (Pubitemid 41170553)
4. Stanley, S. A., J. E. Johndrow, P. Manzanillo, and J. S. Cox. 2007. The type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis. J. Immunol. 178: 3143-3152. (Pubitemid 46333196)
5. Yang, Y., C. Yin, A. Pandey, D. Abbott, C. Sassetti, and M. A. Kelliher. 2007. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2. J. Biol. Chem. 282: 36223-36229.
6. Vance, R. E., R. R. Isberg, and D. A. Portnoy. 2009. Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system. Cell Host Microbe 6: 10-21.
7. Abdallah, A. M., N. C. Gey van Pittius, P. A. Champion, J. Cox, J. Luirink, C. M. Vandenbroucke-Grauls, B. J. Appelmelk, and W. Bitter. 2007. Type VII secretion: mycobacteria show the way. Nat. Rev. Microbiol. 5: 883-891. (Pubitemid 47578389)
8. Pym, A. S., P. Brodin, R. Brosch, M. Huerre, and S. T. Cole. 2002. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol. Microbiol. 46: 709-717. (Pubitemid 35365606)
9. Mahairas, G. G., P. J. Sabo, M. J. Hickey, D. C. Singh, and C. K. Stover. 1996. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J. Bacteriol. 178: 1274-1282. (Pubitemid 26073382)
10. Koo, I. C., C. Wang, S. Raghavan, J. H. Morisaki, J. S. Cox, and E. J. Brown. 2008. ESX-1-dependent cytolysis in lysosome secretion and inflammasome activation during mycobacterial infection. Cell. Microbiol. 10: 1866-1878.
11. Kurenuma, T., I. Kawamura, H. Hara, R. Uchiyama, S. Daim, S. R. Dewamitta, S. Sakai, K. Tsuchiya, T. Nomura, and M. Mitsuyama. 2009. The RD1 locus in the Mycobacterium tuberculosis genome contributes to activation of caspase-1 via induction of potassium ion efflux in infected macrophages. Infect. Immun. 77: 3992-4001.
12. Mishra, B. B., P. Moura-Alves, A. Sonawane, N. Hacohen, G. Griffiths, L. F. Moita, and E. Anes. 2010. Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome. Cell. Microbiol. 12: 1046-1063.
13. Pandey, A. K., Y. Yang, Z. Jiang, S. M. Fortune, F. Coulombe, M. A. Behr, K. A. Fitzgerald, C. M. Sassetti, and M. A. Kelliher. 2009. NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathog. 5: e1000500.
14. Fremond, C. M., D. Togbe, E. Doz, S. Rose, V. Vasseur, I. Maillet, M. Jacobs, B. Ryffel, and V. F. Quesniaux. 2007. IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection. J. Immunol. 179: 1178-1189.
15. Mayer-Barber, K. D., D. L. Barber, K. Shenderov, S. D. White, M. S. Wilson, A. Cheever, D. Kugler, S. Hieny, P. Caspar, G. Núñez, et al. 2010. Caspase-1 independent IL-1β production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo. J. Immunol. 184: 3326-3330.
16. Master, S. S., S. K. Rampini, A. S. Davis, C. Keller, S. Ehlers, B. Springer, G. S. Timmins, P. Sander, and V. Deretic. 2008. Mycobacterium tuberculosis prevents inflammasome activation. Cell Host Microbe 3: 224-232. (Pubitemid 351494718)
17. Lazarevic, V., and F. Martinon. 2008. Linking inflammasome activation and phagosome maturation. Cell Host Microbe 3: 199-200. (Pubitemid 351494721)
18. Manca, C., L. Tsenova, A. Bergtold, S. Freeman, M. Tovey, J. M. Musser, C. E. Barry, III, V. H. Freedman, and G. Kaplan. 2001. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β. Proc. Natl. Acad. Sci. USA 98: 5752-5757. (Pubitemid 32435714)
19. Manca, C., L. Tsenova, S. Freeman, A. K. Barczak, M. Tovey, P. J. Murray, C. Barry, and G. Kaplan. 2005. Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. J. Interferon Cytokine Res. 25: 694-701. (Pubitemid 43010524)
20. Ordway, D., M. Henao-Tamayo, M. Harton, G. Palanisamy, J. Troudt, C. Shanley, R. J. Basaraba, and I. M. Orme. 2007. The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation. J. Immunol. 179: 522-531. (Pubitemid 46986569)
21. Antonelli, L. R., A. Gigliotti Rothfuchs, R. Gonçalves, E. Roffê, A. W. Cheever, A. Bafica, A. M. Salazar, C. G. Feng, and A. Sher. 2010. Intranasal poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. J. Clin. Invest. 120: 1674-1682.
22. Berry, M. P., C. M. Graham, F. W. McNab, Z. Xu, S. A. Bloch, T. Oni, K. A. Wilkinson, R. Banchereau, J. Skinner, R. J. Wilkinson, et al. 2010. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973-977.
23. Chaussabel, D., R. T. Semnani, M. A. McDowell, D. Sacks, A. Sher, and T. B. Nutman. 2003. Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood 102: 672-681. (Pubitemid 36841991)
24. Remoli, M. E., E. Giacomini, G. Lutfalla, E. Dondi, G. Orefici, A. Battistini, G. Uzé, S. Pellegrini, and E. M. Coccia. 2002. Selective expression of type I IFN genes in human dendritic cells infected with Mycobacterium tuberculosis. J. Immunol. 169: 366-374. (Pubitemid 34686157)
25. Feng, C. G., M. Kaviratne, A. G. Rothfuchs, A. Cheever, S. Hieny, H. A. Young, T. A. Wynn, and A. Sher. 2006. NK cell-derived IFN-γ differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis. J. Immunol. 177: 7086-7093. (Pubitemid 44715076)
26. Geiss, G. K., R. E. Bumgarner, B. Birditt, T. Dahl, N. Dowidar, D. L. Dunaway, H. P. Fell, S. Ferree, R. D. George, T. Grogan, et al. 2008. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat. Biotechnol. 26: 317-325. (Pubitemid 351355126)
27. Benjamini, Y., and Y. Hochberg. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol. 57: 289-300.
28. Pestka, S. 2007. The interferons: 50 years after their discovery, there is much more to learn. J. Biol. Chem. 282: 20047-20051. (Pubitemid 47099975)
29. Hu, X., H. H. Ho, O. Lou, C. Hidaka, and L. B. Ivashkiv. 2005. Homeostatic role of interferons conferred by inhibition of IL-1-mediated inflammation and tissue destruction. J. Immunol. 175: 131-138. (Pubitemid 40884309)
30. Dinarello, C. A., T. Ikejima, S. J. Warner, S. F. Orencole, G. Lonnemann, J. G. Cannon, and P. Libby. 1987. Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. J. Immunol. 139: 1902-1910. (Pubitemid 17141622)
31. Schindler, R., P. Ghezzi, and C. A. Dinarello. 1990. IL-1 induces IL-1. IV. IFN-γsuppresses IL-1 but not lipopolysaccharide-induced transcription of IL-1. J. Immunol. 144: 2216-2222. (Pubitemid 20106563)
32. Kalliolias, G. D., R. A. Gordon, and L. B. Ivashkiv. 2010. Suppression of TNF-αand IL-1 signaling identifies a mechanism of homeostatic regulation of macrophages by IL-27. J. Immunol. 185: 7047-7056.
33. Henry, T., A. Brotcke, D. S. Weiss, L. J. Thompson, and D. M. Monack. 2007. Type I interferon signaling is required for activation of the inflammasome during Francisella infection. J. Exp. Med. 204: 987-994. (Pubitemid 46798143)
34. Netea, M. G., C. A. Nold-Petry, M. F. Nold, L. A. Joosten, B. Opitz, J. H. Van der Meer, F. L. Van de Veerdonk, G. Ferwerda, B. Heinhuis, I. Devesa, et al. 2009. Differential requirement for the activation of the inflammasome for processing and release of IL-1β in monocytes and macrophages. Blood 113: 2324-2335.
35. Netea, M. G., A. Simon, F. Van de Veerdonk, B. J. Kullberg, J. W. Van der Meer, and L. A. Joosten. 2010. IL-1β processing in host defense: beyond the inflammasomes. PLoS Pathog. 6: e1000661.
36. Monroe, K. M., S. M. McWhirter, and R. E. Vance. 2010. Induction of type I interferons by bacteria. Cell. Microbiol. 12: 881-890.
37. Trinchieri, G. 2010. Type I interferon: friend or foe? J. Exp. Med. 207: 2053-2063.
38. Ramgolam, V. S., Y. Sha, J. Jin, X. Zhang, and S. Markovic-Plese. 2009. IFN-βinhibits human Th17 cell differentiation. J. Immunol. 183: 5418-5427.
39. Henry, T., G. S. Kirimanjeswara, T. Ruby, J. W. Jones, K. Peng, M. Perret, L. Ho, J. D. Sauer, Y. Iwakura, D. W. Metzger, and D. M. Monack. 2010. Type I IFN signaling constrains IL-17A/F secretion by gd T cells during bacterial infections. J. Immunol. 184: 3755-3767.
40. Radwan, M., R. Stiefvater, T. Grunert, O. Sharif, I. Miller, M. Marchetti-Deschmann, G. Allmaier, M. Gemeiner, S. Knapp, P. Kovarik, et al. 2010. Tyrosine kinase 2 controls IL-1β production at the translational level. J. Immunol. 185: 3544-3553.
41. Guarda, G., M. Braun, F. Staehli, A. Tardivel, C. Mattmann, I. Förster, M. Farlik, T. Decker, R. A. Du Pasquier, P. Romero, and J. Tschopp. 2011. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 34: 213-223.
42. Fortune, S. M., A. Solache, A. Jaeger, P. J. Hill, J. T. Belisle, B. R. Bloom, E. J. Rubin, and J. D. Ernst. 2004. Mycobacterium tuberculosis inhibits macrophage responses to IFN-γ through myeloid differentiation factor 88-dependent and -independent mechanisms. J. Immunol. 172: 6272-6280. (Pubitemid 38621234)
43. Kincaid, E. Z., and J. D. Ernst. 2003. Mycobacterium tuberculosis exerts gene-selective inhibition of transcriptional responses to IFN-γ without inhibiting STAT1 function. J. Immunol. 171: 2042-2049. (Pubitemid 36966487)
44. Carlsson, F., J. Kim, C. Dumitru, K. H. Barck, R. A. Carano, M. Sun, L. Diehl, and E. J. Brown. 2010. Host-detrimental role of Esx-1-mediated inflammasome activation in mycobacterial infection. PLoS Pathog. 6: e1000895.
45. Volkman, H. E., T. C. Pozos, J. Zheng, J. M. Davis, J. F. Rawls, and L. Ramakrishnan. 2010. Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium. Science 327: 466-469.
46. Sabbatani, S., R. Manfredi, G. Marinacci, M. Pavoni, L. Cristoni, and F. Chiodo. 2006. Reactivation of severe, acute pulmonary tuberculosis during treatment with pegylated interferon-a and ribavirin for chronic HCV hepatitis. Scand. J. Infect. Dis. 38: 205-208.
47. Tsai, M. C., M. C. Lin, and C. H. Hung. 2009. Successful antiviral and antituberculosis treatment with pegylated interferon-alfa and ribavirin in a chronic hepatitis C patient with pulmonary tuberculosis. J. Formos. Med. Assoc. 108: 746-750.
48. Behar, S. M., M. Divangahi, and H. G. Remold. 2010. Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? Nat. Rev. Microbiol. 8: 668-674.
49. Harding, C. V., and W. H. Boom. 2010. Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors. Nat. Rev. Microbiol. 8: 296-307.